Previous 10 | Next 10 |
In a regulatory filing yesterday, Emergent BioSolutions (EBS +2.4%) said it had received inquiries and subpoenas from a range of U.S. authorities regarding its ability to conduct COVID-19 vaccine manufacturing. The company’s production plant in Baltimore was subject to an FDA insp...
The following slide deck was published by Emergent BioSolutions Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Emergent BioSolutions Inc. 2021 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Emergent BioSolutions inc (NYSE: EBS) Q2 2021 Earnings Call Jul 29, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions inc (EBS) Q2 2021 Earnings Call Transcript
Emergent Biosolutions, Inc. (EBS) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Bob Burrows – Investor Relations Bob Kramer – President and Chief Executive Officer Rich Lindahl – Chief Financial Officer Conference Call Participants Brandon...
Emergent Biosolutions (NYSE:EBS): Q2 Non-GAAP EPS of $0.33 misses by $1.23; GAAP EPS of $0.09 misses by $1.24. Revenue of $397.5M (+0.7% Y/Y) misses by $3.67M. Reaffirmed 2021 Outlook: Total revenues $1,700 - $1,900M; NARCAN® Nasal Spray $305 - $325M; Anthrax vaccines $280...
Reaffirms 2021 Full Year Forecast for Revenues and Profit GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2021. “Our second quarter performance demonstr...
GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview manufacturing facility to resume production of Johnson & Johnson’s (J&J) Covid...
Emergent BioSolutions joins forces with an alliance of advocacy organizations that share a common goal to empower open communication and address the stigma of opioid overdoses, which are oftentimes accidental. Professional football player Darren Waller and lifestyle influencer Dani ...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July
GAITHERSBURG, Md., July 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 29, 2021 at 5:00 pm eastern time to discuss the financial results for the second quarter of 2021, recent business developments, revenue guidance for the ...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...